Home / Articles / Tetrazoles for biomedicine

Tetrazoles for biomedicine

Elena Aleksandrovna Popova 1
Elena Aleksandrovna Popova
, 
Rostislav Evgen'evich Trifonov 1, 2
Rostislav Evgen'evich Trifonov
, 
Vladimir Aronovich Ostrovskii 2
Vladimir Aronovich Ostrovskii
1 Saint Petersburg State University
2 State Technological Institute of St. Petersburg (Technical University)
10.1070/RCR4864
Published 30 November 2018
Review , RCR4864, Volume 88, Issue 6, 644-676
116
Share
Cite this
GOST
 | 
Cite this
GOST
Copy cite
Popova E. A., Trifonov R. E., Ostrovskii V. A. Tetrazoles for biomedicine // Russian Chemical Reviews. 2018. Vol. 88. No. 6. pp. 644-676.
GOST all authors (up to 50)
Copy cite
Popova E. A., Trifonov R. E., Ostrovskii V. A. Tetrazoles for biomedicine // Russian Chemical Reviews. 2018. Vol. 88. No. 6. pp. 644-676.
RIS
 | 
Cite this
RIS
Copy cite
TY - JOUR
DO - 10.1070/RCR4864
UR - https://rcr.colab.ws/publications/10.1070/RCR4864
TI - Tetrazoles for biomedicine
T2 - Russian Chemical Reviews
AU - Popova, Elena Aleksandrovna
AU - Trifonov, Rostislav Evgen'evich
AU - Ostrovskii, Vladimir Aronovich
PY - 2018
DA - 2018/11/30
PB - ANO Editorial Board of the journal Uspekhi Khimii
SP - 644-676
IS - 6
VL - 88
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors)
Copy cite
@article{2018_Popova,
author = {Elena Aleksandrovna Popova and Rostislav Evgen'evich Trifonov and Vladimir Aronovich Ostrovskii},
title = {Tetrazoles for biomedicine},
journal = {Russian Chemical Reviews},
year = {2018},
volume = {88},
publisher = {ANO Editorial Board of the journal Uspekhi Khimii},
month = {Nov},
url = {https://rcr.colab.ws/publications/10.1070/RCR4864},
number = {6},
pages = {644--676},
doi = {10.1070/RCR4864}
}
MLA
Cite this
MLA
Copy cite
Popova, Elena Aleksandrovna, et al. “Tetrazoles for biomedicine.” Russian Chemical Reviews, vol. 88, no. 6, Nov. 2018, pp. 644-676. https://rcr.colab.ws/publications/10.1070/RCR4864.
Views / Visits / Downloads
28 / 27 / 12

Abstract

The tetrazole ring is an important pharmacophore. It is a structural component in many drugs, drug candidates (or lead compounds) and various biochemical reagents. This review summarizes data on the use of tetrazoles in biomedicine published in the last 10--15 years and also views on the nature of their biological effects. The prospects for the development of new biologically active substances containing a tetrazolyl pharmacophore are analyzed.

The bibliography includes 263 references.

Funders

Russian Science Foundation
17-13-01124

References

1.
Drugs in the tetrazole series. (Review)
Myznikov L.V., Hrabalek A., Koldobskii G.I.
Chemistry of Heterocyclic Compounds , 2007
2.
rcr_88_6_644_bib2
Ostrovskii
2008
3.
rcr_88_6_644_bib3
Mohite
Int. J. PharmTech Res. , 2011
4.
Medicinal chemistry of tetrazoles
Ostrovskii V.A., Trifonov R.E., Popova E.A.
Russian Chemical Bulletin , 2012
5.
rcr_88_6_644_bib5
Ostrovskii
2017
9.
The Hydrogen Bond Environments of 1H-Tetrazole and Tetrazolate Rings: The Structural Basis for Tetrazole–Carboxylic Acid Bioisosterism
Allen F.H., Groom C.R., Liebeschuetz J.W., Bardwell D.A., Olsson T.S., Wood P.A.
Journal of Chemical Information and Modeling , 2012
13.
Tetrazole acetic acid: Tautomers, conformers, and isomerization
Araujo-Andrade C., Reva I., Fausto R.
Journal of Chemical Physics , 2014
14.
α-1H-1,2,3,4-Tetrazole
Goddard R., Heinemann O., Krüger C.
Acta Crystallographica Section C Crystal Structure Communications , 1997
15.
rcr_88_6_644_bib15
Sokolova
Zh. Org. Khim. , 1975
16.
Low temperature matrix-isolation and solid state vibrational spectra of tetrazole
Bugalho S.C., Maçôas E.M., Lurdes S. Cristiano M., Fausto R.
Physical Chemistry Chemical Physics , 2001
17.
A theoretical study of the tautomerism and ionization of 5-substituted NH-tetrazoles
Trifonov R.E., Alkorta I., Ostrovskii V.A., Elguero J.
Journal of Molecular Structure THEOCHEM , 2004
18.
Protolytic equilibria in tetrazoles
Trifonov R.E., Ostrovskii V.A.
Russian Journal of Organic Chemistry , 2006
19.
rcr_88_6_644_bib19
Maharramov
2016
20.
Hydrogen bonding of 1- and 2-substituted tetrazoles with conventional proton donors
Oparina Y.R., Trifonov R.E.
Russian Journal of Organic Chemistry , 2013
22.
Steroids: partial synthesis in medicinal chemistry
Hanson J.R.
Natural Product Reports , 2010
23.
Selective antitumour activity and ERα molecular docking studies of newly synthesizedd-homo fused steroidal tetrazoles
Penov-Gaši K.M., Oklješa A.M., Petri E.T., Ćelić A.S., Djurendić E.A., Klisurić O.R., Csanadi J.J., Batta G., Nikolić A.R., Jakimov D.S., Sakač M.N.
MedChemComm , 2013
24.
Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structure
Yan S., Larson G., Wu J.Z., Appleby T., Ding Y., Hamatake R., Hong Z., Yao N.
Bioorganic and Medicinal Chemistry Letters , 2007
25.
Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives
Carini D.J., Duncia J.V., Aldrich P.E., Chiu A.T., Johnson A.L., Pierce M.E., Price W.A., Santella J.B., Wells G.J.
Journal of Medicinal Chemistry , 1991
26.
Comparative QSAR:  Angiotensin II Antagonists
Kurup A., Garg R., Carini D.J., Hansch C.
Chemical Reviews , 2001
27.
Development of 3D-QSAR CoMSIA models for 5-(biphenyl-2-yl)-1H-tetrazole derivatives as angiotensin II receptor type 1 (AT1) antagonists
Choi M.J., Kwon G.H., Han N.S., Yoo B.W., Kim J.H., Paik S.H., Chi Y.H., Lee K., Lee J.Y.
Bioorganic and Medicinal Chemistry Letters , 2013
28.
6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships
Ries U.J., Mihm G., Narr B., Hasselbach K.M., Wittneben H., Entzeroth M., van Meel J.C., Wienen W., Hauel N.H.
Journal of Medicinal Chemistry , 1993
30.
Design, synthesis, and evaluation of imidazo[4,5-c]pyridin-4-one derivatives with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ
Casimiro-Garcia A., Heemstra R.J., Bigge C.F., Chen J., Ciske F.A., Davis J.A., Ellis T., Esmaeil N., Flynn D., Han S., Jalaie M., Ohren J.F., Powell N.A.
Bioorganic and Medicinal Chemistry Letters , 2013
31.
Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists—A perspective
Naik P., Murumkar P., Giridhar R., Yadav M.R.
Bioorganic and Medicinal Chemistry , 2010
32.
rcr_88_6_644_bib32
Sharma
J. Optoelectron. Biomed. Mat. , 2010
33.
rcr_88_6_644_bib33
Sharma
Med. Chem. Res. , 2012
34.
Tetrazole Derivatives as Promising Anticancer Agents
Popova E.A., Protas A.V., Trifonov R.E.
Anti-Cancer Agents in Medicinal Chemistry , 2017
35.
rcr_88_6_644_bib35
Topală
Farmacia , 2014
36.
Synthesis, DNA and BSA binding of Pd(II) and Pt(II) complexes featuring tetrazolylacetic acids and their esters
Protas A.V., Popova E.A., Mikolaichuk O.V., Porozov Y.B., Mehtiev A.R., Ott I., Alekseev G.V., Kasyanenko N.A., Trifonov R.E.
Inorganica Chimica Acta , 2018
37.
rcr_88_6_644_bib37
McIntyre
Pharmacol. Ther. , 1997
38.
Valsartan, a potent, orally active angiotensin II antagonist developed from the structurally new amino acid series
Bühlmayer P., Furet P., Criscione L., de Gasparo M., Whitebread S., Schmidlin T., Lattmann R., Wood J.
Bioorganic and Medicinal Chemistry Letters , 1994
40.
rcr_88_6_644_bib40
Maillard
J. Pharmacol. Exp. Ther. , 2000
41.
Clinical Efficacy of a New Angiotensin II Type 1 Receptor Blocker, Pratosartan, in Hypertensive Patients
OGIHARA T., SARUTA T., SHIMAMOTO K., MATSUOKA H., RAKUGI H.
Hypertension Research , 2008
43.
Fimasartan, a novel angiotensin II receptor antagonist
Kim J.H., Lee J.H., Paik S.H., Kim J.H., Chi Y.H.
Archives of Pharmacal Research , 2012
44.
rcr_88_6_644_bib44
Timmermans
Can. J. Cardiol. , 1999
45.
Pharmacological Profile of a Non-peptidic Dual Inhibitor of Neutral Endopeptidase 24.11 and Endothelin-Converting Enzyme
Delombaert S., Ghai R.D., Jeng A.Y., Trapani A.J., Webb R.L.
Biochemical and Biophysical Research Communications , 1994
46.
Characterization of CGS 31447, a potent and nonpeptidic endothelin-converting enzyme inhibitor.
Shetty S.S., Savage P., DelGrande D., De Lombaert S., Jeng A.Y.
Journal of Cardiovascular Pharmacology , 2003
47.
Design and Synthesis of Potent, Selective Inhibitors of Endothelin-Converting Enzyme
Wallace E.M., Moliterni J.A., Moskal M.A., Neubert A.D., Marcopulos N., Stamford L.B., Trapani A.J., Savage P., Chou M., Jeng A.Y.
Journal of Medicinal Chemistry , 1998
48.
Potent and Selective Non-Peptidic Inhibitors of Endothelin-Converting Enzyme-1 with Sustained Duration of Action
De Lombaert S., Blanchard L., Stamford L.B., Tan J., Wallace E.M., Satoh Y., Fitt J., Hoyer D., Simonsbergen D., Moliterni J., Marcopoulos N., Savage P., Chou M., Trapani A.J., Jeng A.Y., et. al.
Journal of Medicinal Chemistry , 2000
49.
Discovery and Evaluation of Potent P1 Aryl Heterocycle-Based Thrombin Inhibitors
Young M.B., Barrow J.C., Glass K.L., Lundell G.F., Newton C.L., Pellicore J.M., Rittle K.E., Selnick H.G., Stauffer K.J., Vacca J.P., Williams P.D., Bohn D., Clayton F.C., Cook J.J., Krueger J.A., et. al.
Journal of Medicinal Chemistry , 2004
50.
A One-Pot Asymmetric Synthesis of a N-Acylated 4,5-Dihydropyrazole, A Key Intermediate of Thrombin Inhibitor AZD8165
Karlsson S., Brånalt J., Ölwegård Halvarsson M., Bergman J.
Organic Process Research and Development , 2014
51.
Nonbenzamidine tetrazole derivatives as factor Xa inhibitors
Quan M.L., Ellis C.D., He M.Y., Liauw A.Y., Woerner F.J., Alexander R.S., Knabb R.M., Lam P.Y., Luettgen J.M., Wong P.C., Wright M.R., Wexler R.R.
Bioorganic and Medicinal Chemistry Letters , 2003
54.
rcr_88_6_644_bib54
Asif
Pharm. Methods , 2014
55.
rcr_88_6_644_bib55
Grayson
2010
56.
Synthesis and Molecular and Crystal Structure of 1-(5-Benzyl-2-tetrazolyl)-1-cyclopentanecarboxylic Acid. Penicillin and Cephalosporins Based on This Acid
Martirosyan A.O., Aleksanyan M.V., Terzyan S.S., Ter‐Zakharyan Y.Z., Agababyan R.V., Karapetyan A.A., Mndzhoyan S.L., Tamazyan R.A.
Pharmaceutical Chemistry Journal , 2001
57.
Microwave-Assisted Solid-Phase Synthesis of Cephalosporin Derivatives with Antibacterial Activity
Kidwai M., Misra P., Bhushan K.R., Saxena R.K., Singh M.
Monatshefte fur Chemie , 2000
58.
Synthesis and antibacterial activity of metal complexes of cefazolin
Anacona J.R., Alvarez P.
Transition Metal Chemistry , 2002
59.
Metalloantibiotics: Synthesis and Antibacterial Activity of Cobalt(II), Copper(II), Nickel(II) and Zinc(II) Complexes of Kefzol
Chohan Z.H., Supuran C.T., Scozzafava A.
Journal of Enzyme Inhibition and Medicinal Chemistry , 2004
61.
Cefonicid
Saltiel E., Brogden R.N.
Drugs , 1986
62.
rcr_88_6_644_bib62
Garzone
Drug Intell. Clin. Pharm. , 1983
63.
rcr_88_6_644_bib63
Li
RSC Adv. , 2015
64.
Enzymatic synthesis of β-lactam acids (review)
Sklyarenko A.V., El’darov M.A., Kurochkina V.B., Yarotsky S.V.
Applied Biochemistry and Microbiology , 2015
68.
Targeting metallo-β-lactamase enzymes in antibiotic resistance
King D.T., Strynadka N.C.
Future Medicinal Chemistry , 2013
69.
Analysis of US FDA-Approved Drugs Containing Sulfur Atoms
Scott K.A., Njardarson J.T.
Topics in Current Chemistry , 2018
70.
Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing
Ayers L.W., Jones R.N., Barry A.L., Thornsberry C., Fuchs P.C., Gavan T.L., Gerlach E.H., Sommers H.M.
Antimicrobial Agents and Chemotherapy , 1982
71.
Effects of various cephem antibiotics on ethanol metabolism and their structure-activity relations
Kamei C., Sugimoto Y., Muroi N., Tasaka K.
Journal of Pharmacy and Pharmacology , 1986
73.
rcr_88_6_644_bib73
Anacona
2012
75.
rcr_88_6_644_bib75
Shan
Drug Des. Devel. Ther. , 2014
76.
Clarithromycin Targets Neutrophilic Airway Inflammation in Refractory Asthma
Simpson J.L., Powell H., Boyle M.J., Scott R.J., Gibson P.G.
American Journal of Respiratory and Critical Care Medicine , 2007
79.
rcr_88_6_644_bib79
Sofan
Der Pharma Chem. , 2012
80.
Synthesis and Antimicrobial Activity of New Tetrazoles Incorporating Isoindole-1,3-dione Moiety and Their Sugar Derivatives
Abdel-Rahman A.A., Ali O.M., Abdel-Megeed A.A.
Journal of Heterocyclic Chemistry , 2013
83.
Structure-Activity Relationships of Diverse Oxazolidinones for Linezolid-Resistant Staphylococcus aureus Strains Possessing the cfr Methyltransferase Gene or Ribosomal Mutations
Locke J.B., Finn J., Hilgers M., Morales G., Rahawi S., G. C. K., Picazo J.J., Im W., Shaw K.J., Stein J.L.
Antimicrobial Agents and Chemotherapy , 2010
84.
Copper Catalyzed Assembly ofN-Aryloxazolidinones: Synthesis of Linezolid, Tedizolid, and Rivaroxaban
Mahy W., Leitch J.A., Frost C.G.
European Journal of Organic Chemistry , 2016
85.
Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent.
Im W.B., Choi S.H., Park J., Choi S.H., Finn J., Yoon S.
European Journal of Medicinal Chemistry , 2011
86.
Design at the atomic level: Design of biaryloxazolidinones as potent orally active antibiotics
Zhou J., Bhattacharjee A., Chen S., Chen Y., Duffy E., Farmer J., Goldberg J., Hanselmann R., Ippolito J.A., Lou R., Orbin A., Oyelere A., Salvino J., Springer D., Tran J., et. al.
Bioorganic and Medicinal Chemistry Letters , 2008
88.
Biphenyl tetrazole-thiazolidinediones as novel bacterial peptide deformylase inhibitors: Synthesis, biological evaluations and molecular docking study
Khan F.A., Jadhav K.S., Patil R.H., Shinde D.B., Arote R.B., Sangshetti J.N.
Biomedicine and Pharmacotherapy , 2016
90.
Homo- and Heteroleptic Bismuth(III/V) Thiolates from N-Heterocyclic Thiones: Synthesis, Structure and Anti-Microbial Activity
Luqman A., Blair V.L., Brammananth R., Crellin P.K., Coppel R.L., Andrews P.C.
Chemistry - A European Journal , 2014
91.
Synthesis, biological evaluation and molecular docking studies on the DNA and BSA binding interactions of palladium(II) and platinum(II) complexes featuring amides of tetrazol-1-yl- and tetrazol-5-ylacetic acids
Popova E.A., Protas A.V., Mukhametshina A.V., Ovsepyan G.K., Suezov R.V., Eremin A.V., Stepchenkova E.I., Tarakhovskaya E.R., Fonin A.V., Starova G.L., Mikolaichuk O.V., Porozov Y.B., Gureev M.A., Trifonov R.E.
Polyhedron , 2019
92.
Methylation of Ir(iii)-tetrazolato complexes: an effective route to modulate the emission outputs and to switch to antimicrobial properties
Fiorini V., Zanoni I., Zacchini S., Costa A.L., Hochkoeppler A., Zanotti V., Ranieri A.M., Massi M., Stefan A., Stagni S.
Dalton Transactions , 2017
93.
5-(1-Aryl-3-(thiophen-2-yl)-1H-pyrazol-4-yl)-1H-tetrazoles: Synthesis, structural characterization, Hirshfeld analysis, anti-inflammatory and anti-bacterial studies
Kumbar M.N., Kamble R.R., Dasappa J.P., Bayannavar P.K., Khamees H.A., Mahendra M., Joshi S.D., Dodamani S., Rasal V.P., Jalalpure S.
Journal of Molecular Structure , 2018
94.
Ultrasound-assisted synthesis and antimicrobial activity of tetrazole-based pyrazole and pyrimidine derivatives
Dofe V.S., Sarkate A.P., Shaikh Z.M., Gill C.H.
Heterocyclic Communications , 2017
97.
rcr_88_6_644_bib97
Bayomi
J. Am. Sci. , 2016
98.
Tolba M.S., El-Dean A.M., Ahmed M., Hassanien R., Farouk M.
Arkivoc , 2017
101.
Synthesis, in vitro antibacterial and antifungal evaluations of new alpha-hydroxyphosphonate and new alpha-acetoxyphosphonate derivatives of tetrazolo [1, 5-a] quinoline.
Kategaonkar A.H., Pokalwar R.U., Sonar S.S., Gawali V.U., Shingate B.B., Shingare M.S.
European Journal of Medicinal Chemistry , 2010
102.
Synthesis, antimicrobial activity and cytotoxic investigation of novel trifluoromethylated tetrazolo[1,5-a]pyrimidines
Scapin E., Frizzo C.P., Rodrigues L.V., Zimmer G.C., Vaucher R.A., Sagrillo M.R., Giongo J.L., Afonso C.A., Rijo P., Zanatta N., Bonacorso H.G., Martins M.A.
Medicinal Chemistry Research , 2017
103.
Synthesis, antibacterial and QSAR evaluation of 5-oxo and 5-thio derivatives of 1,4-disubstituted tetrazoles
Morjan R.Y., Al-Attar N.H., Abu-Teim O.S., Ulrich M., Awadallah A.M., Mkadmh A.M., Elmanama A.A., Raftery J., Abu-Awwad F.M., Yaseen Z.J., Elqidrea A.F., Gardiner J.M.
Bioorganic and Medicinal Chemistry Letters , 2015
105.
Bulky organosilicon compounds based on sulfanyltetrazoles: their synthesis and in vitro antibacterial evaluation
Baghershiroudi M., Safa K.D., Adibkia K., Lotfipour F.
Journal of the Iranian Chemical Society , 2018
106.
Pharmacological Inhibition of the ClpXP Protease Increases Bacterial Susceptibility to Host Cathelicidin Antimicrobial Peptides and Cell Envelope-Active Antibiotics
McGillivray S.M., Tran D.N., Ramadoss N.S., Alumasa J.N., Okumura C.Y., Sakoulas G., Vaughn M.M., Zhang D.X., Keiler K.C., Nizet V.
Antimicrobial Agents and Chemotherapy , 2012
109.
Synthesis, antimicrobial activity and anti-biofilm activity of novel tetrazole derivatives
Dofe V.S., Sarkate A.P., Kathwate S.H., Gill C.H.
Heterocyclic Communications , 2017
110.
Synthesis and Antimicrobial Activity of Substituted Nitrotetrazole-5-Carbaldehyde Hydrazones
Tyrkov A.G., Abdelraheem M.A., Sukhenko L.T.
Pharmaceutical Chemistry Journal , 2014
111.
Tetrazole-Based trans -Translation Inhibitors Kill Bacillus anthracis Spores To Protect Host Cells
Alumasa J.N., Goralski T.D., Keiler K.C.
Antimicrobial Agents and Chemotherapy , 2017
112.
Inhibitors of Ribosome Rescue Arrest Growth of Francisella tularensis at All Stages of Intracellular Replication
Goralski T.D., Dewan K.K., Alumasa J.N., Avanzato V., Place D.E., Markley R.L., Katkere B., Rabadi S.M., Bakshi C.S., Keiler K.C., Kirimanjeswara G.S.
Antimicrobial Agents and Chemotherapy , 2016
113.
Novel tetrazoloquinoline–rhodanine conjugates: Highly efficient synthesis and biological evaluation
Subhedar D.D., Shaikh M.H., Nawale L., Yeware A., Sarkar D., Khan F.A., Sangshetti J.N., Shingate B.B.
Bioorganic and Medicinal Chemistry Letters , 2016
114.
New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents
Chauhan K., Sharma M., Trivedi P., Chaturvedi V., Chauhan P.M.
Bioorganic and Medicinal Chemistry Letters , 2014
115.
The design, synthesis, in silico ADME profiling, antiplasmodial and antimycobacterial evaluation of new arylamino quinoline derivatives
Tukulula M., Little S., Gut J., Rosenthal P.J., Wan B., Franzblau S.G., Chibale K.
European Journal of Medicinal Chemistry , 2012
116.
rcr_88_6_644_bib116
Suresh
Chem. Select. , 2016
117.
rcr_88_6_644_bib117
Patil
Arch. Pharm. , 2018
118.
1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria
Karabanovich G., Roh J., Smutný T., Němeček J., Vicherek P., Stolaříková J., Vejsová M., Dufková I., Vávrová K., Pávek P., Klimešová V., Hrabálek A.
European Journal of Medicinal Chemistry , 2014
119.
Tetrazole regioisomers in the development of nitro group-containing antitubercular agents
Karabanovich G., Roh J., Soukup O., Pávková I., Pasdiorová M., Tambor V., Stolaříková J., Vejsová M., Vávrová K., Klimešová V., Hrabálek A.
MedChemComm , 2015
120.
Structure-activity relationship studies on 3,5-dinitrophenyl tetrazoles as antitubercular agents
Němeček J., Sychra P., Macháček M., Benková M., Karabanovich G., Konečná K., Kavková V., Stolaříková J., Hrabálek A., Vávrová K., Soukup O., Roh J., Klimešová V.
European Journal of Medicinal Chemistry , 2017
121.
Development of water-soluble 3,5-dinitrophenyl tetrazole and oxadiazole antitubercular agents
Roh J., Karabanovich G., Vlčková H., Carazo A., Němeček J., Sychra P., Valášková L., Pavliš O., Stolaříková J., Klimešová V., Vávrová K., Pávek P., Hrabálek A.
Bioorganic and Medicinal Chemistry , 2017
122.
Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-β-lactamase
Toney J.H., Fitzgerald P.M., Grover-Sharma N., Olson S.H., May W.J., Sundelof J.G., Vanderwall D.E., Cleary K.A., Grant S.K., Wu J.K., Kozarich J.W., Pompliano D.L., Hammond G.G.
Chemistry & Biology , 1998
123.
Progress toward inhibitors of metallo-β-lactamases
McGeary R.P., Tan D.T., Schenk G.
Future Medicinal Chemistry , 2017
124.
Structure-Based Virtual Screening for the Discovery of Novel Inhibitors of New Delhi Metallo-β-lactamase-1
Spyrakis F., Celenza G., Marcoccia F., Santucci M., Cross S., Bellio P., Cendron L., Perilli M., Tondi D.
ACS Medicinal Chemistry Letters , 2017
125.
Design, synthesis and biological evaluation of non-covalent AmpC β-lactamases inhibitors
Genovese F., Lazzari S., Venturi E., Costantino L., Blazquez J., Ibacache-Quiroga C., Costi M.P., Tondi D.
Medicinal Chemistry Research , 2017
126.
Antibacterial Spectrum of a Tetrazole-Based Reversible Inhibitor of Serine β-Lactamases
Pemberton O.A., Zhang X., Nichols D.A., DeFrees K., Jaishankar P., Bonnet R., Adams J., Shaw L.N., Renslo A.R., Chen Y.
Antimicrobial Agents and Chemotherapy , 2018
127.
In Vitro and In Vivo Antifungal Activities of TAK-456, a Novel Oral Triazole with a Broad Antifungal Spectrum
Tsuchimori N., Hayashi R., Kitamoto N., Asai K., Kitazaki T., Iizawa Y., Itoh K., Okonogi K.
Antimicrobial Agents and Chemotherapy , 2002
128.
Design and optimization of highly-selective fungal CYP51 inhibitors
Hoekstra W.J., Garvey E.P., Moore W.R., Rafferty S.W., Yates C.M., Schotzinger R.J.
Bioorganic and Medicinal Chemistry Letters , 2014
129.
Design and optimization of highly-selective, broad spectrum fungal CYP51 inhibitors
Yates C.M., Garvey E.P., Shaver S.R., Schotzinger R.J., Hoekstra W.J.
Bioorganic and Medicinal Chemistry Letters , 2017
131.
Design, synthesis, and evaluations of antifungal activity of novel phenyl(2H-tetrazol-5-yl)methanamine derivatives
Salake A.B., Chothe A.S., Nilewar S.S., Khilare M., Meshram R.S., Pandey A.A., Kathiravan M.K.
Journal of Chemical Biology , 2013
132.
Tetrazolylmethyl quinolines: Design, docking studies, synthesis, anticancer and antifungal analyses
Shaikh S.K., Kamble R.R., Somagond S.M., Devarajegowda H.C., Dixit S.R., Joshi S.D.
European Journal of Medicinal Chemistry , 2017
133.
rcr_88_6_644_bib133
Vembu
J. Pharm. Res. , 2014
134.
rcr_88_6_644_bib134
Vembu
Der Pharma Chem. , 2014
136.
Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafungin
Apgar J.M., Wilkening R.R., Greenlee M.L., Balkovec J.M., Flattery A.M., Abruzzo G.K., Galgoci A.M., Giacobbe R.A., Gill C.J., Hsu M.J., Liberator P., Misura A.S., Motyl M., Nielsen Kahn J., Powles M., et. al.
Bioorganic and Medicinal Chemistry Letters , 2015
138.
In Vitro Studies of Chromone-Tetrazoles against Pathogenic Protozoa, Bacteria, and Fungi
Cano P., Islas-Jácome A., Rangel-Serrano Á., Anaya-Velázquez F., Padilla-Vaca F., Trujillo-Esquivel E., Ponce-Noyola P., Martínez-Richa A., Gámez-Montaño R.
Molecules , 2015
139.
Synthesis and Antifungal Activity of Substituted Nitrotetrazole-5-Carbaldehyde Hydrazones
Tyrkov A.G., Abdel’rakhim M.A., Sukhenko L.T., Degtyarev O.V.
Pharmaceutical Chemistry Journal , 2014
140.
New 1,5 and 2,5-disubstituted tetrazoles-dependent activity towards surface barrier of Candida albicans
Staniszewska M., Gizińska M., Mikulak E., Adamus K., Koronkiewicz M., Łukowska-Chojnacka E.
European Journal of Medicinal Chemistry , 2018
142.
Effectiveness of Novel 5-(5-amino-1-aryl-1H-pyrazol-4-yl)-1H-tetrazole Derivatives Against Promastigotes and Amastigotes ofLeishmania amazonensis
dos Santos Faiões V., Leon L.L., Canto-Cavalheiro M.M., Torres-Santos E.C., Bernardino A.M., Vegi P.F., dos Santos M.S.
Chemical Biology and Drug Design , 2013
143.
An insight into tetrahydro-β-carboline–tetrazole hybrids: synthesis and bioevaluation as potent antileishmanial agents
Purohit P., Pandey A.K., Singh D., Chouhan P.S., Ramalingam K., Shukla M., Goyal N., Lal J., Chauhan P.M.
MedChemComm , 2017
144.
rcr_88_6_644_bib144
May
2002
146.
Synthesis and anti-influenza activity of 2-cyanoethoxy and 2-(1H-tetrazol-5-yl)ethoxy derivatives of dammarane-type triterpenoids
Zorina A.D., Kaledina A.S., Motsepuro I.A., Anokhina V.V., Marchenko S.A., Selivanov S.I., Zarubaev V.V., Trifonov R.E.
Russian Journal of Organic Chemistry , 2017
147.
Thymidine- and AZT-linked 5-(1,3-dioxoalkyl)tetrazoles and 4-(1,3-dioxoalkyl)-1,2,3-triazoles
Bosch L., Delelis O., Subra F., Deprez E., Witvrow M., Vilarrasa J.
Tetrahedron Letters , 2012
148.
Catechol-Substituted l -Chicoric acid analogues as HIV integrase inhibitors
Lee J.Y., Yoon K.J., Lee Y.S.
Bioorganic and Medicinal Chemistry Letters , 2003
150.
Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus
Zarubaev V.V., Golod E.L., Anfimov P.M., Shtro A.A., Saraev V.V., Gavrilov A.S., Logvinov A.V., Kiselev O.I.
Bioorganic and Medicinal Chemistry , 2010
151.
Synthesis, Structure, and Anti-influenza Activity of 2-(Adamantan-1-yl)-5-aryl-1,3,4-oxadiazoles and 2-(Adamantan-1-yl)-5-aryltetrazoles
Seliverstova D.V., Suslonov V.V., Zarubaev V.V., Trifonov R.E.
Russian Journal of Organic Chemistry , 2018
152.
Inhibitors of HIV-1 attachment. Part 9: An assessment of oral prodrug approaches to improve the plasma exposure of a tetrazole-containing derivative
Yeung K., Qiu Z., Yang Z., Zadjura L., D’Arienzo C.J., Browning M.R., Hansel S., Huang X.S., Eggers B.J., Riccardi K., Lin P., Meanwell N.A., Kadow J.F.
Bioorganic and Medicinal Chemistry Letters , 2013
153.
Inhibitors of HIV-1 attachment. Part 7: Indole-7-carboxamides as potent and orally bioavailable antiviral agents
Yeung K., Qiu Z., Xue Q., Fang H., Yang Z., Zadjura L., D’Arienzo C.J., Eggers B.J., Riccardi K., Shi P., Gong Y., Browning M.R., Gao Q., Hansel S., Santone K., et. al.
Bioorganic and Medicinal Chemistry Letters , 2013
154.
Inhibitors of HIV-1 attachment. Part 8: The effect of C7-heteroaryl substitution on the potency, and in vitro and in vivo profiles of indole-based inhibitors
Yeung K., Qiu Z., Yin Z., Trehan A., Fang H., Pearce B., Yang Z., Zadjura L., D’Arienzo C.J., Riccardi K., Shi P., Spicer T.P., Gong Y., Browning M.R., Hansel S., et. al.
Bioorganic and Medicinal Chemistry Letters , 2013
156.
Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors
Al-Hourani B.J., Sharma S.K., Mane J.Y., Tuszynski J., Baracos V., Kniess T., Suresh M., Pietzsch J., Wuest F.
Bioorganic and Medicinal Chemistry Letters , 2011
160.
Structure–activity relationship of novel series of 1,5-disubstituted tetrazoles as cyclooxygenase-2 inhibitors: Design, synthesis, bioassay screening and molecular docking studies
Jawabrah Al-Hourani B., Al-Awaida W., Matalka K.Z., El-Barghouthi M.I., Alsoubani F., Wuest F.
Bioorganic and Medicinal Chemistry Letters , 2016
162.
rcr_88_6_644_bib162
Sathishkumar
Indian J. Chem. Sect. B , 2017
163.
Synthesis, characterization, crystal structure, in-vitro anti-inflammatory and molecular docking studies of 5-mercapto-1-substituted tetrazole incorporated quinoline derivative
Sureshkumar K., Maheshwaran V., Dharma Rao T., Themmila K., Ponnuswamy M.N., Kadhirvel S., Dhandayutham S.
Journal of Molecular Structure , 2017
164.
Liposome formulations of combretastatin A4 and 4-arylcoumarin analog prodrugs: Antitumor effect in the mouse model of breast cancer
Moiseeva E.V., Kuznetsova N.R., Svirshchevskaya E.V., Bovin N.V., Sitnikov N.S., Shavyrin A.S., Beletskaya I.P., Combes S., Fedorov A.Y., Vodovozova E.L.
Biomeditsinskaya Khimiya , 2012
165.
Medicinal Chemistry of Combretastatin A4:  Present and Future Directions
Tron G.C., Pirali T., Sorba G., Pagliai F., Busacca S., Genazzani A.A.
Journal of Medicinal Chemistry , 2006
166.
Combretastatin A-4 Analogs as Anticancer Agents
Chaudhary A., Pandeya S., Kumar P., Sharma P., Gupta S., Soni N., Verma K., Bhardwaj G.
Mini-Reviews in Medicinal Chemistry , 2007
167.
Novel cis-restricted β-lactam combretastatin A-4 analogues display anti-vascular and anti-metastatic properties in vitro
NATHWANI S., HUGHES L., GREENE L.M., CARR M., O’BOYLE N.M., McDONNELL S., MEEGAN M.J., ZISTERER D.M.
Oncology Reports , 2012
168.
rcr_88_6_644_bib168
Perevalov
Usp. Khim. Khim. Tekhnol. , 2012
169.
Synthesis and Evaluation of 1,5-Disubstituted Tetrazoles as Rigid Analogues of Combretastatin A-4 with Potent Antiproliferative and Antitumor Activity
Romagnoli R., Baraldi P.G., Salvador M.K., Preti D., Aghazadeh Tabrizi M., Brancale A., Fu X., Li J., Zhang S., Hamel E., Bortolozzi R., Basso G., Viola G.
Journal of Medicinal Chemistry , 2011
170.
Correlation of hydrogen-bonding propensity and anticancer profile of tetrazole-tethered combretastatin analogues
Jedhe G.S., Paul D., Gonnade R.G., Santra M.K., Hamel E., Nguyen T.L., Sanjayan G.J.
Bioorganic and Medicinal Chemistry Letters , 2013
171.
A-Ring Dihalogenation Increases the Cellular Activity of Combretastatin-Templated Tetrazoles
Beale T.M., Allwood D.M., Bender A., Bond P.J., Brenton J.D., Charnock-Jones D.S., Ley S.V., Myers R.M., Shearman J.W., Temple J., Unger J., Watts C.A., Xian J.
ACS Medicinal Chemistry Letters , 2012
172.
Synthesis and biological evaluation of cis -restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers
Subba Rao A.V., Swapna K., Shaik S.P., Lakshma Nayak V., Srinivasa Reddy T., Sunkari S., Shaik T.B., Bagul C., Kamal A.
Bioorganic and Medicinal Chemistry , 2017
173.
Impact of Natural Products on Developing New Anti-Cancer Agents
Cragg G.M., Grothaus P.G., Newman D.J.
Chemical Reviews , 2009
174.
Biological Evaluation of New Largazole Analogues: Alteration of Macrocyclic Scaffold with Click Chemistry
Li X., Tu Z., Li H., Liu C., Li Z., Sun Q., Yao Y., Liu J., Jiang S.
ACS Medicinal Chemistry Letters , 2012
175.
Design and Synthesis of Potent Non-Polyglutamatable Quinazoline Antifolate Thymidylate Synthase Inhibitors
Marsham P.R., Wardleworth J.M., Boyle F.T., Hennequin L.F., Kimbell R., Brown M., Jackman A.L.
Journal of Medicinal Chemistry , 1999
176.
Design and synthesis of Cyclopenta[g]quinazoline-based antifolates as inhibitors of thymidylate synthase and potential antitumor agents(,).
Bavetsias V., Marriott J.H., Melin C., Kimbell R., Matusiak Z.S., Boyle F.T., Jackman A.L.
Journal of Medicinal Chemistry , 2000
177.
Synthesis of steroids with nitrogen-containing substituents in ring D (Review)
Stulov S.V., Misharin A.Y.
Chemistry of Heterocyclic Compounds , 2013
178.
rcr_88_6_644_bib178
Shamsuzzaman
Eur. Chem. Bull. , 2014
179.
Computational and anti-tumor studies of 7a-Aza-B-homostigmast-5-eno [7a, 7-d] tetrazole-3β-yl chloride
Alam M., Alam M.J., Nami S.A., Lee D., Azam M., Ahmad S.
Journal of Molecular Structure , 2016
180.
Synthesis and Biological evaluation of novel 4β-[(5-substituted)-1,2,3,4-tetrazolyl] podophyllotoxins as anticancer compounds
Hyder I., Yedlapudi D., Kalivendi S.V., Khazir J., Ismail T., Nalla N., Miryala S., Sampath Kumar H.M.
Bioorganic and Medicinal Chemistry Letters , 2015
181.
Specific Conformational Change in Giant DNA Caused by Anticancer Tetrazolato-Bridged Dinuclear Platinum(II) Complexes: Middle-Length Alkyl Substituents Exhibit Minimum Effect.
Komeda S., Yoneyama H., Uemura M., Muramatsu A., Okamoto N., Konishi H., Takahashi H., Takagi A., Fukuda W., Imanaka T., Kanbe T., Harusawa S., Yoshikawa Y., Yoshikawa K.
Inorganic Chemistry , 2017
182.
Conformational transition of DNA by dinuclear Pt(II) complexes causes cooperative inhibition of gene expression
Shimizu Y., Yoshikawa Y., Kenmotsu T., Komeda S., Yoshikawa K.
Chemical Physics Letters , 2017
183.
rcr_88_6_644_bib183
Imai
Sci. Rep. , 2016
187.
Highly Efficient DNA Compaction Mediated by an In Vivo Antitumor-Active Tetrazolato-Bridged Dinuclear Platinum(II) Complex
Yoshikawa Y., Komeda S., Uemura M., Kanbe T., Chikuma M., Yoshikawa K., Imanaka T.
Inorganic Chemistry , 2011
189.
Preparation of bis(5-phenyltetrazolato) Pt(II) and Pt(IV) analogues of transplatin and in vitro evaluation for antitumor activity
Perfahl S., Bodtke A., Pracharova J., Kasparkova J., Brabec V., Cuadrado J., Stürup S., Schulzke C., Bednarski P.J.
Inorganica Chimica Acta , 2017
190.
rcr_88_6_644_bib190
Popova
2016
191.
Novel water soluble palladium(II) complexes featuring tetrazolylacetic acids and their esters
Protas A.V., Popova E.A., Suslonov V.V., Trifonov R.E.
Polyhedron , 2017
192.
rcr_88_6_644_bib192
Mandal
Appl. Organomet. Chem. , 2017
193.
Exploring saccharinate-tetrazoles as selective Cu(ii) ligands: structure, magnetic properties and cytotoxicity of copper(ii) complexes based on 5-(3-aminosaccharyl)-tetrazoles
Ismael A., Henriques M.S., Marques C., Rodrigues M., Barreira L., Paixão J.A., Fausto R., Cristiano M.L.
RSC Advances , 2016
194.
Synthesis of polybrominated benzimidazole and benzotriazole derivatives containing a tetrazole ring and their cytotoxic activity
Łukowska-Chojnacka E., Wińska P., Wielechowska M., Bretner M.
Monatshefte fur Chemie , 2016
195.
rcr_88_6_644_bib195
ElMonaem
J. Appl. Pharm. Sci. , 2018
196.
1H-Tetrazol-5-amine and 1,3-thiazolidin-4-one derivatives containing 3-(trifluoromethyl)phenyl scaffold: Synthesis, cytotoxic and anti-HIV studies
Bielenica A., Szulczyk D., Olejarz W., Madeddu S., Giliberti G., Materek I.B., Koziol A.E., Struga M.
Biomedicine and Pharmacotherapy , 2017
197.
Design, synthesis and biological evaluation of benzamide and phenyltetrazole derivatives with amide and urea linkers as BCRP inhibitors
Gujarati N.A., Zeng L., Gupta P., Chen Z., Korlipara V.L.
Bioorganic and Medicinal Chemistry Letters , 2017
198.
Gomha S.M., Muhammad Z.A., Abdel-aziz H.M., El-Arab E.E.
Croatica Chemica Acta , 2018
201.
rcr_88_6_644_bib201
Mashkovsky
2017
202.
The Chemical Induction of Seizures in Psychiatric Therapy
Cooper K., Fink M.
Journal of Clinical Psychopharmacology , 2014
205.
rcr_88_6_644_bib205
Chapouthier
Med. Chem. Rev. , 2004
208.
DL-Tetrazol-5-ylglycine, a highly potent NMDA agonist: its synthesis and NMDA receptor efficacy
Lunn W.H., Schoepp D.D., Calligaro D.O., Vasileff R.T., Heinz L.J., Salhoff C.R., O'Malley P.J.
Journal of Medicinal Chemistry , 1992
211.
Synthesis and pharmacological characterization of l-trans-4-tetrazolylproline (ly300020): A novel systemically-active ampa receptor agonist
Monn J.A., Valli M.J., True R.A., Schoepp D.D., Leander J.D., Lodge D.
Bioorganic and Medicinal Chemistry Letters , 1993
212.
Structural Basis for AMPA Receptor Activation and Ligand Selectivity: Crystal Structures of Five Agonist Complexes with the GluR2 Ligand-binding Core
Hogner A., Kastrup J.S., Jin R., Liljefors T., Mayer M.L., Egebjerg J., Larsen I.K., Gouaux E.
Journal of Molecular Biology , 2002
214.
Tetrazolyl isoxazole amino acids as ionotropic glutamate receptor antagonists: Synthesis, modelling and molecular pharmacology
Frølund B., Greenwood J.R., Holm M.M., Egebjerg J., Madsen U., Nielsen B., Bräuner-Osborne H., Stensbøl T.B., Krogsgaard-Larsen P.
Bioorganic and Medicinal Chemistry , 2005
215.
LY293558, a Novel AMPA/GluR5 Antagonist, is Efficacious and Well-Tolerated in Acute Migraine
Sang C., Ramadan N., Wallihan R., Chappell A., Freitag F., Smith T., Silberstein S., Johnson K., Phebus L., Bleakman D., Ornstein P., Arnold B., Tepper S., Vandenhende F.
Cephalalgia , 2004
216.
Structure−Activity Studies of 6-(Tetrazolylalkyl)-Substituted Decahydroisoquinoline-3-carboxylic Acid AMPA Receptor Antagonists. 1. Effects of Stereochemistry, Chain Length, and Chain Substitution
Ornstein P.L., Arnold M.B., Allen N.K., Bleisch T., Borromeo P.S., Lugar C.W., Leander J.D., Lodge D., Schoepp D.D.
Journal of Medicinal Chemistry , 1996
217.
Structure−Activity Studies of 6-Substituted Decahydroisoquinoline-3-carboxylic Acid AMPA Receptor Antagonists. 2. Effects of Distal Acid Bioisosteric Substitution, Absolute Stereochemical Preferences, and in Vivo Activity
Ornstein P.L., Arnold M.B., Allen N.K., Bleisch T., Borromeo P.S., Lugar C.W., Leander J.D., Lodge D., Schoepp D.D.
Journal of Medicinal Chemistry , 1996
218.
4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of action
Ornstein P.L., Schoepp D.D., Arnold M.B., Leander J.D., Lodge D., Paschal J.W., Elzey T.
Journal of Medicinal Chemistry , 1991
219.
Heteroatom-substitution as a strategy for increasing the potency of competitive NMDA antagonists
Ornstein P.L., Arnold M.B., Lunn W.H., Heinz L.J., Leander J.D., Lodge D., Schoepp D.D.
Bioorganic and Medicinal Chemistry Letters , 1998
220.
Synthesis of C5-tetrazole derivatives of 2-amino-adipic acid displaying NMDA glutamate receptor antagonism
Lenda F., Crouzin N., Cavalier M., Guiramand J., Lanté F., Barbanel G., Cohen-Solal C., Martinez J., Guenoun F., Lamaty F., Vignes M.
Amino Acids , 2010
221.
Regional distribution and pharmacological characteristics of [3H]N-acetyl-aspartyl-glutamate (NAAG) binding sites in rat brain
Shave E., Pliss L., Lawrance M.L., FitzGibbon T., Stastny F., Balcar V.J.
Neurochemistry International , 2001
224.
Metabotropic glutamate receptors: structure and new subtype-selective ligands
Pellicciari R., Costantino G., Marinozzi M., Macchiarulo A., Camaioni E., Natalini B.
Il Farmaco , 2001
226.
rcr_88_6_644_bib226
Dong
Arch. Pharm. , 2017
227.
Design, synthesis and evaluation of 5-substituted 1-H-tetrazoles as potent anticonvulsant agents
Liao A., Wang T., Cai B., Jin Y., Cheon S., Chun C., Wang Z.
Archives of Pharmacal Research , 2016
231.
Synthesis and anticonvulsant activity evaluation of 6-substituted-[1,2,4]triazolo[3,4-a](tetrazolo[5,1-a])phthalazine derivatives
Bian M., Deng X., Gong G., Wei C., Quan Z.
Journal of Enzyme Inhibition and Medicinal Chemistry , 2012
232.
BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease
Ghosh A.K., Osswald H.L.
Chemical Society Reviews , 2014
233.
BACE1 inhibitors: Optimization by replacing the P1′ residue with non-acidic moiety
Hamada Y., Abdel-Rahman H., Yamani A., Nguyen J., Stochaj M., Hidaka K., Kimura T., Hayashi Y., Saito K., Ishiura S., Kiso Y.
Bioorganic and Medicinal Chemistry Letters , 2008
234.
Significance of interactions of BACE1–Arg235 with its ligands and design of BACE1 inhibitors with P2 pyridine scaffold
Hamada Y., Ohta H., Miyamoto N., Sarma D., Hamada T., Nakanishi T., Yamasaki M., Yamani A., Ishiura S., Kiso Y.
Bioorganic and Medicinal Chemistry Letters , 2009
235.
Design of pentapeptidic BACE1 inhibitors with carboxylic acid bioisosteres at P1′ and P4 positions
Tagad H.D., Hamada Y., Nguyen J., Hamada T., Abdel-Rahman H., Yamani A., Nagamine A., Ikari H., Igawa N., Hidaka K., Sohma Y., Kimura T., Kiso Y.
Bioorganic and Medicinal Chemistry , 2010
236.
Investigation of α-phenylnorstatine and α-benzylnorstatine as transition state isostere motifs in the search for new BACE-1 inhibitors
Wångsell F., Nordeman P., Sävmarker J., Emanuelsson R., Jansson K., Lindberg J., Rosenquist Å., Samuelsson B., Larhed M.
Bioorganic and Medicinal Chemistry , 2011
237.
Novel BACE1 inhibitors possessing a 5-nitroisophthalic scaffold at the P2 position
Hamada Y., Nakanishi T., Suzuki K., Yamaguchi R., Hamada T., Hidaka K., Ishiura S., Kiso Y.
Bioorganic and Medicinal Chemistry Letters , 2012
238.
Discovery of pyrazole as C-terminus of selective BACE1 inhibitors
Zou Y., Xu L., Chen W., Zhu Y., Chen T., Fu Y., Li L., Ma L., Xiong B., Wang X., Li J., He J., Zhang H., Xu Y., Li J., et. al.
European Journal of Medicinal Chemistry , 2013
239.
Nitrogen-appended N-alkylsulfonamides as inhibitors of γ-secretase
Bergstrom C.P., Sloan C.P., Wang H.H., Parker M.F., Smith D.W., Zheng M., Hansel S.B., Polson C.T., Barber L.E., Bursuker I., Guss V.L., Corsa J.A., Barten D.M., Felsenstein K.M., Roberts S.B., et. al.
Bioorganic and Medicinal Chemistry Letters , 2008
240.
One-pot synthesis of tetrazole-1,2,5,6-tetrahydronicotinonitriles and cholinesterase inhibition: Probing the plausible reaction mechanism via computational studies
Hameed A., Zehra S.T., Abbas S., Nisa R.U., Mahmood T., Ayub K., al-Rashida M., Bajorath J., Khan K.M., Iqbal J.
Bioorganic Chemistry , 2016
241.
GluK1 antagonists from 6-(tetrazolyl)phenyl decahydroisoquinoline derivatives: In vitro profile and in vivo analgesic efficacy
Martinez-Perez J.A., Iyengar S., Shannon H.E., Bleakman D., Alt A., Clawson D.K., Arnold B.M., Bell M.G., Bleisch T.J., Castaño A.M., Del Prado M., Dominguez E., Escribano A.M., Filla S.A., Ho K.H., et. al.
Bioorganic and Medicinal Chemistry Letters , 2013
245.
rcr_88_6_644_bib245
Khanage
Adv. Pharm. Bull. , 2013
246.
rcr_88_6_644_bib246
Kumari
Int. J. Pharm. Pharm. Sci. , 2013
247.
Development of a credible 3D-QSAR CoMSIA model and docking studies for a series of triazoles and tetrazoles containing 11β-HSD1 inhibitors
Murumkar P.R., Shinde A.C., Sharma M.K., Yamaguchi H., Miniyar P.B., Yadav M.R.
SAR and QSAR in Environmental Research , 2016
248.
Synthesis and structure–activity relationship of 2-adamantylmethyl tetrazoles as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)
Ye X., Yoon D., Chen S.Y., Nayeem A., Golla R., Seethala R., Wang M., Harper T., Sleczka B.G., Apedo A., Li Y., He B., Kirby M., Gordon D.A., Robl J.A., et. al.
Bioorganic and Medicinal Chemistry Letters , 2014
249.
Synthesis and biological evaluation of some N-(3-(1H-tetrazol-5-yl) phenyl)acetamide derivatives as novel non-carboxylic PTP1B inhibitors designed through bioisosteric modulation
Maheshwari N., Karthikeyan C., Bhadada S.V., Sahi C., Verma A.K., Hari Narayana Moorthy N.S., Trivedi P.
Bioorganic Chemistry , 2018
250.
Arif M., Jabeen F., Saeed A., Qureshi I.Z., Mushtaq N.
Bangladesh Journal of Pharmacology , 2017
251.
Discovery, synthesis and in combo studies of a tetrazole analogue of clofibric acid as a potent hypoglycemic agent
Navarrete-Vázquez G., Alaniz-Palacios A., Hidalgo-Figueroa S., González-Acevedo C., Ávila-Villarreal G., Estrada-Soto S., Webster S.P., Medina-Franco J.L., López-Vallejo F., Guerrero-Álvarez J., Tlahuext H.
Bioorganic and Medicinal Chemistry Letters , 2013
252.
Biopharmaceutical Characterization and Bioavailability Study of a Tetrazole Analog of Clofibric Acid in Rat
Vara-Gama N., Valladares-Méndez A., Navarrete-Vazquez G., Estrada-Soto S., Orozco-Castellanos L., Rivera-Leyva J.
Molecules , 2017
253.
Discovery of novel benzo[b]thiophene tetrazoles as non-carboxylate GPR40 agonists
Huang H., Winters M.P., Meegalla S.K., Arnoult E., Paul Lee S., Zhao S., Martin T., Rady B., Liu J., Towers M., Otieno M., Xu F., Lim H.K., Silva J., Pocai A., et. al.
Bioorganic and Medicinal Chemistry Letters , 2018
254.
Reddivari C.K., Devineni S.R., Venkateshwarulu J.K., Baki V.B., Chippada A.R., Wudayagiri R., Venkata R.R., Chamarthi N.R.
European Journal of Chemistry , 2017
255.
Design, Synthesis, Antioxidant and Antibacterial Activities of Novel 2-((1-Benzyl-1H-1,2,3-Triazol-4-yl)methyl)-5-(2HChromen- 3-yl)-2H-Tetrazoles
Srinivas B., Kumar P.V., Nagendra Reddy P., Venu S., Shyam P., David Krupadanam G.L.
Russian Journal of Bioorganic Chemistry , 2018
256.
rcr_88_6_644_bib256
Kale
Int. J. Pharma Bio Sci. , 2014
257.
Synthesis and electrochemical and antioxidant properties of chalcogenocyanate oxadiazole and 5-heteroarylchalcogenomethyl-1H-tetrazole derivatives
Leal J.G., Sauer A.C., Mayer J.C., Stefanello S.T., Gonçalves D.F., Soares F.A., Iglesias B.A., Back D.F., Rodrigues O.E., Dornelles L.
New Journal of Chemistry , 2017
259.
Synthesis and Insecticidal Activity of Tetrazole-Linked Triazole Derivatives
Maddila S., Pagadala R., Jonnalagadda S.B.
Journal of Heterocyclic Chemistry , 2014
260.
Discovery of a tetrazolyl β-carboline within vitroandin vivoosteoprotective activity under estrogen-deficient conditions
Karvande A., Khan S., Khan I., Singh D., Khedgikar V., Kushwaha P., Ahmad N., Kothari P., Dhasmana A., Kant R., Trivedi R., Chauhan P.M.
MedChemComm , 2018
261.
Tetrazolium dyes as tools in cell biology: New insights into their cellular reduction
Berridge M.V., Herst P.M., Tan A.S.
Biotechnology Annual Review , 2005
262.
An Efficient Method for the Isolation and Purification of Oligoribonucleotides
Sproat B., Colonna F., Mullah B., Tsou D., Andrus A., Hampel A., Vinayak R.
Nucleosides and Nucleotides , 1995